AIFF

Add to Watchlist

Advanced Chart

0.000

0(0.000%)1D

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Firefly Neuroscience Inc (AIFF.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Firefly Neuroscience Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider
Hedge Fund
Congress Trading

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

AIFF News & Events

Events Timeline

(ET)

2025-12-03

17:10:00

Firefly Neuroscience Files $250M Mixed Securities Shelf

2025-11-12 (ET)

2025-11-12

07:47:55

Firefly Neuroscience announces Q3 earnings per share of 20 cents, compared to a loss of 61 cents in the same period last year.

2025-09-05 (ET)

2025-09-05

07:57:12

Firefly Neuroscience Collaborates with HealingMaps for Electrophysiology Analysis

News

Preview

7.0

10-09PRnewswire

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)

Preview

2.0

09-25TipRanks

What’s Causing RedCloud Stock (RCT) to Decline in Pre-Market Trading Today?

Preview

4.5

08-30Benzinga

Benzinga Market Movers: Eli Lilly, Firefly, Marvell — Trump Investment Signals Propel Defense Stocks

Market Overview

August Performance: The S&P 500 ended August with a 0.6% decline on the last trading day but achieved a 1.9% gain for the month, marking its fourth consecutive monthly increase. The Dow and Nasdaq also saw slight declines, yet year-to-date performance remains strong.
Inflation Concerns: Elevated inflation, highlighted by a 2.9% core PCE, has created uncertainty regarding the Federal Reserve's timeline for rate cuts, despite optimistic signals from Fed Chair Jerome Powell.

Notable Stock Movements

Tech Sector Decline: Major tech stocks like Dell, Marvell, and Nvidia experienced declines, while MongoDB and Snowflake reported significant gains driven by strong AI-related earnings.
Upcoming Reports: Investors are keenly awaiting the upcoming PCE inflation report, which could influence expectations for a September rate cut amidst ongoing inflation and policy uncertainties.

Bullish Highlights

Defense Stocks Surge: Reports indicate that the Trump administration is considering acquiring stakes in major defense contractors such as Boeing, Lockheed Martin, and Palantir Technologies, with Lockheed earning 97% of its revenue from federal contracts.
Eli Lilly's Weight-Loss Pill: Eli Lilly's stock rose after announcing Phase 3 trial results for its oral GLP-1 pill, orforglipron, which showed an average weight loss of 10.5% among patients, boosting investor confidence.
Firefly Neuroscience's AI Platform: Firefly Neuroscience's stock jumped 31% following the launch of its AI-powered EEG platform, which utilizes Nvidia's L40S GPU to enhance brain signal data quality.

Bearish Highlights

Marvell's Stock Drop: Marvell Technology's stock fell 16% after its Q2 results were overshadowed by disappointing Q3 sales guidance, despite analysts acknowledging long-term potential in AI and optical growth.
Tesla's Trust Issues: A survey revealed that nearly half of Americans believe Tesla's Full Self-Driving feature should be illegal, with 70% favoring vehicles equipped with both LiDAR and cameras, contrasting with Tesla's camera-only approach.
Nutanix's Mixed Earnings: Nutanix's shares declined after a strong Q4 earnings report, which included revenue of $653.26 million that exceeded estimates, but investor enthusiasm waned due to concerns over subscription sales and cautious guidance.

Stock Performance Snapshot

Key Stock Prices:
- Boeing (BA): $234.28, -0.80%
- Eli Lilly (LLY): $730.75, -0.16%
- Marvell (MRVL): $63.00, -18.4%
- Nvidia (NVDA): $173.67, -3.61%
- Tesla (TSLA): $333.86, -3.50%

This content was produced with AI assistance and reviewed by Benzinga editors.

People Also Watch

FAQ

What is Firefly Neuroscience Inc (AIFF) stock price today?

What is Firefly Neuroscience Inc (AIFF)'s business?

What is the price predicton of AIFF Stock?

What is Firefly Neuroscience Inc (AIFF)'s revenue for the last quarter?

What is Firefly Neuroscience Inc (AIFF)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Firefly Neuroscience Inc (AIFF)'s fundamentals?

How many employees does Firefly Neuroscience Inc (AIFF). have?

What is Firefly Neuroscience Inc (AIFF) market cap?

Trading Trends

Insider
Hedge Fund
Congress Trading

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

AIFF News & Events

Events Timeline

(ET)

2025-12-03

17:10:00

Firefly Neuroscience Files $250M Mixed Securities Shelf

2025-11-12 (ET)

2025-11-12

07:47:55

Firefly Neuroscience announces Q3 earnings per share of 20 cents, compared to a loss of 61 cents in the same period last year.

2025-09-05 (ET)

2025-09-05

07:57:12

Firefly Neuroscience Collaborates with HealingMaps for Electrophysiology Analysis

News

Preview

7.0

10-09PRnewswire

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)

Preview

2.0

09-25TipRanks

What’s Causing RedCloud Stock (RCT) to Decline in Pre-Market Trading Today?

Preview

4.5

08-30Benzinga

Benzinga Market Movers: Eli Lilly, Firefly, Marvell — Trump Investment Signals Propel Defense Stocks

Market Overview

August Performance: The S&P 500 ended August with a 0.6% decline on the last trading day but achieved a 1.9% gain for the month, marking its fourth consecutive monthly increase. The Dow and Nasdaq also saw slight declines, yet year-to-date performance remains strong.
Inflation Concerns: Elevated inflation, highlighted by a 2.9% core PCE, has created uncertainty regarding the Federal Reserve's timeline for rate cuts, despite optimistic signals from Fed Chair Jerome Powell.

Notable Stock Movements

Tech Sector Decline: Major tech stocks like Dell, Marvell, and Nvidia experienced declines, while MongoDB and Snowflake reported significant gains driven by strong AI-related earnings.
Upcoming Reports: Investors are keenly awaiting the upcoming PCE inflation report, which could influence expectations for a September rate cut amidst ongoing inflation and policy uncertainties.

Bullish Highlights

Defense Stocks Surge: Reports indicate that the Trump administration is considering acquiring stakes in major defense contractors such as Boeing, Lockheed Martin, and Palantir Technologies, with Lockheed earning 97% of its revenue from federal contracts.
Eli Lilly's Weight-Loss Pill: Eli Lilly's stock rose after announcing Phase 3 trial results for its oral GLP-1 pill, orforglipron, which showed an average weight loss of 10.5% among patients, boosting investor confidence.
Firefly Neuroscience's AI Platform: Firefly Neuroscience's stock jumped 31% following the launch of its AI-powered EEG platform, which utilizes Nvidia's L40S GPU to enhance brain signal data quality.

Bearish Highlights

Marvell's Stock Drop: Marvell Technology's stock fell 16% after its Q2 results were overshadowed by disappointing Q3 sales guidance, despite analysts acknowledging long-term potential in AI and optical growth.
Tesla's Trust Issues: A survey revealed that nearly half of Americans believe Tesla's Full Self-Driving feature should be illegal, with 70% favoring vehicles equipped with both LiDAR and cameras, contrasting with Tesla's camera-only approach.
Nutanix's Mixed Earnings: Nutanix's shares declined after a strong Q4 earnings report, which included revenue of $653.26 million that exceeded estimates, but investor enthusiasm waned due to concerns over subscription sales and cautious guidance.

Stock Performance Snapshot

Key Stock Prices:
- Boeing (BA): $234.28, -0.80%
- Eli Lilly (LLY): $730.75, -0.16%
- Marvell (MRVL): $63.00, -18.4%
- Nvidia (NVDA): $173.67, -3.61%
- Tesla (TSLA): $333.86, -3.50%

This content was produced with AI assistance and reviewed by Benzinga editors.